E-LIB Suche - Ergebnisse für: Fenton, Keenan

1

Exposure–Response and Subgroup Analyses to Support Body Wei..:

Zhang, Zufei ; Zhang, Daping ; Guo, Wenchuan...
Clinical Cancer Research. 30 (2024) 15 - p. 3273-3281 , 2024

Link: https://doi.org/10.1158/..

2

Time‐varying brentuximab vedotin pharmacokinetics and weigh..:

Zhang, Daping ; Zhang, Zufei ; Lee, Anthony...
British Journal of Clinical Pharmacology. , 2024

Link: https://doi.org/10.1111/..

3

Brentuximab vedotin with chemotherapy in adolescents and yo..:

Crosswell, Howland E. ; LaCasce, Ann S. ; Bartlett, Nancy L....
Haematologica. 109 (2023) 3 - p. 982-987 , 2023

Link: https://doi.org/10.3324/..

4

P009: Improved Overall Survival with First-Line Brentuximab..:

Hutchings, Martin ; Ansell, Stephen M. ; Connors, Joseph M....
HemaSphere. 6 (2022) - p. 4-5 , 2022

Link: https://doi.org/10.1097/..

5

Cost-effectiveness of brentuximab vedotin plus chemotherapy..:

Zou, Denise ; Lee, Joseph ; Kansal, Anuraag...
Journal of Medical Economics. 25 (2022) 1 - p. 324-333 , 2022

Link: https://doi.org/10.1080/..

6

Role of stem cell transplant in CD30+ PTCL following frontl..:

Savage, Kerry J. ; Horwitz, Steven M. ; Advani, Ranjana...
Blood Advances. 6 (2022) 19 - p. 5550-5555 , 2022

Link: https://doi.org/10.1182/..

7

Poster: HL-507 First-Line Brentuximab Vedotin Plus Chemothe..:

Straus, David ; Radford, John ; Connors, Joseph...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S161 , 2022

Link: https://doi.org/10.1016/..

8

Response to Brentuximab Vedotin by CD30 Expression in Non-H..:

Jagadeesh, Deepa ; Horwitz, Steve ; Bartlett, Nancy L...
The Oncologist. 27 (2022) 10 - p. 864-873 , 2022

Link: https://doi.org/10.1093/..

9

HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Imp..:

Straus, David ; Radford, John ; Connors, Joseph...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S350 , 2022

Link: https://doi.org/10.1016/..

10

Poster: HL-147: Brentuximab Vedotin with Chemotherapy for P..:

Ramchandren, Radhakrishnan ; Długosz-Danecka, Monika ; Connors, Joseph M....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S236 , 2021

Link: https://doi.org/10.1016/..

11

TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomize..:

Iyer, Swaminathan ; Trümper, Lorenz ; O'Connor, Owen A....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S411 , 2021

Link: https://doi.org/10.1016/..

12

Brentuximab vedotin plus doxorubicin, vinblastine, and daca..:

Hutchings, Martin ; Radford, John ; Ansell, Stephen M....
Hematological Oncology. 39 (2021) 2 - p. 185-195 , 2021

Link: https://doi.org/10.1002/..

13

HL-147: Brentuximab Vedotin with Chemotherapy for Patients ..:

Ramchandren, Radhakrishnan ; Dfugosz-Danecka, Monika ; Connors, Joseph M....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S371 , 2021

Link: https://doi.org/10.1016/..

14

Poster: TCL-150: The ECHELON-2 Trial: 5-Year Results of a R..:

Iyer, Swaminathan ; Trümper, Lorenz ; O'Connor, Owen A....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S247 , 2021

Link: https://doi.org/10.1016/..

15

Older patients (aged ≥60 years) with previously untreated a..:

Evens, Andrew M. ; Connors, Joseph M. ; Younes, Anas...
Haematologica. 107 (2021) 5 - p. 1086-1094 , 2021

Link: https://doi.org/10.3324/..